Huapont Life Sciences Co., Ltd. (002004.SZ)
CNY 4.64
(-1.28%)
CNY 4.64
(-1.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.58 Billion | 2.4 Billion | 1.26 Billion | 2.37 Billion | 2.08 Billion | 1.9 Billion |
| Net Income | 676.93 Million | 1.12 Billion | 924.96 Million | 895 Million | 931.9 Million | 822.81 Million |
| Depreciation & Amortization | 891.23 Million | 800.22 Million | 747.87 Million | 696.31 Million | 607.14 Million | 586.75 Million |
| Deferred income taxes | -89.88 Million | -68.6 Million | 11.4 Million | -25.51 Million | -60.69 Million | -20.51 Million |
| Stock-based compensation | -2.16 Million | 49.53 Million | - | 12.98 Million | 8.8 Million | 7.47 Million |
| Change in working capital | -689.1 Million | -162.12 Million | -843.94 Million | 294.83 Million | 28.75 Million | -30.66 Million |
| Other non-cash items | 366.88 Million | 662.08 Million | 440.72 Million | 499.09 Million | 566.22 Million | 529.72 Million |
| Investing Cash Flow | -1.74 Billion | -556.49 Million | -790.43 Million | -1.76 Billion | -1.35 Billion | -1.02 Billion |
| Investments in PPE | -1.28 Billion | -1.13 Billion | -1.25 Billion | -1.23 Billion | -1.43 Billion | -1.09 Billion |
| Acquisitions | -3.94 Million | -15.84 Million | -40.08 Million | 29.82 Million | 64.66 Million | -15.41 Million |
| Investment purchases | -6.66 Billion | -7.14 Billion | -7.26 Billion | -10.12 Billion | -7 Billion | -9.95 Billion |
| Sales/Maturities of investments | 6.45 Billion | 7.9 Billion | 7.74 Billion | 9.61 Billion | 6.96 Billion | 9.77 Billion |
| Other Investing Activities | -322.54 Million | -176.39 Million | 24.39 Million | -46.22 Million | 41.29 Million | 268.45 Million |
| Financing Cash Flow | -3.65 Million | -1.37 Billion | -203.77 Million | -239.57 Million | -1.62 Billion | -3.2 Billion |
| Debt repayment | -486.85 Million | -7.89 Billion | -10.27 Billion | -263.07 Million | -627.61 Million | -8.97 Billion |
| Dividends payments | -435.58 Million | -435.58 Million | -435.58 Million | -435.58 Million | -435.58 Million | -987.95 Million |
| Common Stock Repurchased | - | - | - | - | - | -270.35 Million |
| Common Stock Issuance | - | - | - | -4.62 Million | -5.28 Million | - |
| Other Financing Activities | 557.98 Million | 7.38 Billion | 10.93 Billion | 440.44 Million | -33.68 Million | 6.75 Billion |
| Accounts receivables | -587.97 Million | 59.61 Million | -1.03 Billion | -128.78 Million | -29.7 Million | 336.56 Million |
| Accounts payables | 190.67 Million | 1.45 Million | 645.37 Million | 306.91 Million | 264 Million | -331.39 Million |
| Inventory | -201.92 Million | -154.58 Million | -456.08 Million | 142.21 Million | -144.85 Million | -15.32 Million |
| Other working capital | -10.66 Million | -68.6 Million | 6.44 Million | -25.51 Million | -60.69 Million | -15.34 Million |
| Cash at beginning of period | 2.99 Billion | 2.5 Billion | 2.21 Billion | 1.87 Billion | 2.76 Billion | 5.03 Billion |
| Cash at end of period | 2.82 Billion | 2.99 Billion | 2.5 Billion | 2.21 Billion | 1.87 Billion | 2.76 Billion |
| Capital Expenditure | -1.28 Billion | -1.13 Billion | -1.25 Billion | -1.23 Billion | -1.43 Billion | -1.09 Billion |
| Effect of forex changes on cash | 635.14 Thousand | 7.26 Million | 11.06 Million | -30.12 Million | 10.05 Million | 60.72 Million |
| Net cash flow / Change in cash | -163.25 Million | 488.36 Million | 286.47 Million | 342.75 Million | -894.78 Million | -2.26 Billion |
| Free Cash Flow | 305.35 Million | 1.27 Billion | 13.18 Million | 1.14 Billion | 648.66 Million | 809.2 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 138.45 Million | 157.96 Million | 155.55 Million | -202.8 Million | 676.93 Million | 117.78 Million |
| Depreciation & Amortization | - | 261.42 Million | 261.42 Million | 891.23 Million | 891.23 Million | -433.16 Million |
| Deferred income taxes | - | - | - | - | -89.88 Million | - |
| Stock-based compensation | - | - | - | -2.16 Million | -2.16 Million | - |
| Change in working capital | - | -713.97 Million | - | -800.57 Million | -689.1 Million | 645.62 Million |
| Other non-cash items | 414.8 Million | 399.23 Million | -27.67 Million | 731.02 Million | 366.88 Million | 391.3 Million |
| Investing Cash Flow | -174.71 Million | 38.06 Million | -573.04 Million | -1.34 Billion | -1.74 Billion | -625.6 Million |
| Investments in PPE | -167.37 Million | -183.52 Million | -395.03 Million | -365.69 Million | -1.28 Billion | -295.44 Million |
| Acquisitions | 6.91 Million | 108.94 Thousand | 7.02 Million | -30.34 Million | -3.94 Million | 13.21 Million |
| Investment purchases | -4.22 Billion | -3.94 Billion | -3.95 Billion | -2.28 Billion | -6.66 Billion | -1.14 Billion |
| Sales/Maturities of investments | 4.11 Billion | 4.24 Billion | 3.77 Billion | 1.6 Billion | 6.45 Billion | 835.36 Million |
| Other Investing Activities | 107.47 Million | -78.53 Million | -7.4 Million | -295.98 Million | -322.54 Million | -36.98 Million |
| Financing Cash Flow | -360.16 Million | -425.17 Million | 731.46 Million | 461.07 Million | -3.65 Million | -285.69 Million |
| Debt repayment | -378 Million | -285.71 Million | -1.01 Billion | -193.66 Million | -486.85 Million | -2.79 Billion |
| Dividends payments | -82.97 Million | -516.02 Million | -85.74 Million | -435.58 Million | -435.58 Million | -150.6 Million |
| Common Stock Repurchased | 24.96 Million | -24.96 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 100.81 Million | 28.94 Million | -201.32 Million | 407.82 Million | 557.98 Million | 2.66 Billion |
| Accounts receivables | - | -937.88 Million | - | -587.97 Million | -587.97 Million | 336.52 Million |
| Accounts payables | - | - | - | - | 190.67 Million | 22.4 Million |
| Inventory | - | 232.68 Million | - | -201.92 Million | -201.92 Million | 309.1 Million |
| Other working capital | - | -8.77 Million | - | -10.66 Million | -10.66 Million | -22.4 Million |
| Cash at beginning of period | 2.98 Billion | 3.1 Billion | 2.82 Billion | 3.08 Billion | 2.99 Billion | 3.27 Billion |
| Cash at end of period | 2.96 Billion | 2.98 Billion | 3.1 Billion | 2.82 Billion | 2.82 Billion | 3.08 Billion |
| Capital Expenditure | -167.37 Million | -183.52 Million | -395.03 Million | -365.69 Million | -1.28 Billion | -295.44 Million |
| Effect of forex changes on cash | -5.09 Million | 12.98 Million | 6.33 Million | -402.2 Thousand | 635.14 Thousand | 540.13 Thousand |
| Net cash flow / Change in cash | -21.24 Million | -118.41 Million | 276.27 Million | -260.55 Million | -163.25 Million | -189.21 Million |
| Free Cash Flow | 385.87 Million | 112.24 Million | -267.15 Million | 253.19 Million | 305.35 Million | 426.09 Million |
MAGE
FMNL
IVR
SHAH
QCKSF
VICO